Physician profile
Tony T Zhou
NPI 1215381314
$1,100.72
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $410 · 2023: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $236.87 | 2021-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $199.82 | 2022-2023 | Mounjaro, Emgality, Jardiance |
| Abbvie INC. | $107.49 | 2021-2023 | Linzess, Creon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.00 | 2021-2023 | Trulance, Xifaxan |
| Merck Sharp & Dohme LLC | $83.50 | 2022-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Janssen Pharmaceuticals, INC | $63.06 | 2021 | |
| Novo Nordisk INC | $54.77 | 2022 | |
| Exact Sciences Corporation | $48.06 | 2023 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $44.41 | 2021-2023 | Nexletol |
| Ibsa Pharma INC. | $40.00 | 2021 | |
| Amgen INC. | $34.66 | 2022-2023 | Prolia, Evenity |
| Radius Health, INC. | $26.99 | 2023 | Tymlos |
| Almatica Pharma LLC | $20.00 | 2022 | |
| Seqirus USA INC | $19.38 | 2021 | |
| Pfizer INC. | $14.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.